These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31809308)

  • 61. Performance and Acceptability of the FC2 Female Condom When Used With and Without a Silicone Placebo Vaginal Ring-A Randomized, Crossover Trial.
    Nel A; Malherbe M; van Niekerk N; Beksinska M; Greener R; Smit J; Frezieres R; Walsh T
    J Acquir Immune Defic Syndr; 2020 Sep; 85(1):58-65. PubMed ID: 32452973
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The future role of rectal and vaginal microbicides to prevent HIV infection in heterosexual populations: implications for product development and prevention.
    Boily MC; Dimitrov D; Abdool Karim SS; Mâsse B
    Sex Transm Infect; 2011 Dec; 87(7):646-53. PubMed ID: 22110117
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
    Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL
    N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Post-use assay of vaginal rings (VRs) as a potential measure of clinical trial adherence.
    Spence P; Nel A; van Niekerk N; Derrick T; Wilder S; Devlin B
    J Pharm Biomed Anal; 2016 Jun; 125():94-100. PubMed ID: 27016673
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Safety of a silicone elastomer vaginal ring as potential microbicide delivery method in African women: A Phase 1 randomized trial.
    Nel A; Martins J; Bekker LG; Ramjee G; Masenga G; Rees H; van Niekerk N
    PLoS One; 2018; 13(5):e0196904. PubMed ID: 29813074
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Male Partner Opinions of the Dapivirine Vaginal Ring Used During an Open-Label Extension HIV Prevention Trial in KwaZulu-Natal, South Africa.
    Morar NS; Mansoor LE; Naidoo K; Katz AWK; Garcia M; Duma C; Precious Myeni NB; Tshbalala T; Naidoo S; Montgomery ET
    J Acquir Immune Defic Syndr; 2023 Feb; 92(2):127-133. PubMed ID: 36302179
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Using Emoji Stickers to Understand End-User Opinions of the Dapivirine Vaginal Ring for HIV Prevention.
    Katz AWK; Mansoor LE; Tsidya M; Mathebula F; Singh D; Siva S; Akello C; Chitowa TH; Garcia M; Soto-Torres L; Montgomery ET
    AIDS Behav; 2021 Dec; 25(12):3955-3966. PubMed ID: 34180041
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Packing Polymorphism of Dapivirine and Its Impact on the Performance of a Dapivirine-Releasing Silicone Elastomer Vaginal Ring.
    McCoy CF; Murphy DJ; Boyd P; Derrick T; Spence P; Devlin B; Malcolm RK
    J Pharm Sci; 2017 Aug; 106(8):2015-2025. PubMed ID: 28456732
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy and Action of the Dapivirine Vaginal Ring as Understood by Women Participating in an Open Label Extension Study.
    Naidoo K; T ME; Katz AW; Morgan G; Krishnaveni R; Lydia ST; Sarita N; Leila ME
    AIDS Behav; 2023 Jan; 27(1):75-81. PubMed ID: 35672549
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring.
    Romano J; Variano B; Coplan P; Van Roey J; Douville K; Rosenberg Z; Temmerman M; Verstraelen H; Van Bortel L; Weyers S; Mitchnick M
    AIDS Res Hum Retroviruses; 2009 May; 25(5):483-8. PubMed ID: 19388819
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Introducing the Dapivirine Vaginal Ring in Sub-Saharan Africa: What Can We Learn from Oral PrEP?
    Bhavaraju N; Shears K; Schwartz K; Mullick S; Jeckonia P; Murungu J; Persaud U; Vij A; Torjesen K
    Curr HIV/AIDS Rep; 2021 Dec; 18(6):508-517. PubMed ID: 34910276
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence.
    Stoner MCD; Brown ER; Palanee-Phillips T; Mansoor LE; Tembo T; Nair G; Akello C; Seyama L; Jeenarain N; Naidoo L; Mgodi N; Hunidzarira P; Chitukuta M; van der Straten A;
    AIDS Behav; 2021 Dec; 25(12):4169-4179. PubMed ID: 33939034
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis.
    Low N; Chersich MF; Schmidlin K; Egger M; Francis SC; van de Wijgert JH; Hayes RJ; Baeten JM; Brown J; Delany-Moretlwe S; Kaul R; McGrath N; Morrison C; Myer L; Temmerman M; van der Straten A; Watson-Jones D; Zwahlen M; Hilber AM
    PLoS Med; 2011 Feb; 8(2):e1000416. PubMed ID: 21358808
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acceptability of the Dapivirine Vaginal Ring in Postmenopausal US Women.
    Shapley-Quinn MK; Laborde N; Luecke E; Hoesley C; Salata RA; Johnson S; Nel A; Soto-Torres L; Chen BA; van der Straten A
    AIDS Patient Care STDS; 2022 Mar; 36(3):97-105. PubMed ID: 35289688
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sexual behaviours associated with incident high-risk anal human papillomavirus among gay and bisexual men.
    Wong IKJ; Poynten IM; Cornall A; Templeton DJ; Molano M; Garland SM; Fairley CK; Law C; Hillman RJ; Polizzotto MN; Grulich AE; Jin F;
    Sex Transm Infect; 2022 Mar; 98(2):101-107. PubMed ID: 33727339
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The relationship between vaginal ring use and intimate partner violence and social harms: formative research outcomes from the CHARISMA study in Johannesburg, South Africa.
    Hartmann M; Palanee-Phillips T; O'Rourke S; Adewumi K; Tenza S; Mathebula F; Wagner D; Ayub A; Montgomery ET
    AIDS Care; 2019 Jun; 31(6):660-666. PubMed ID: 30309246
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preventive Misconception and Risk Behaviors in a Multinational HIV Prevention Trial.
    Sugarman J; Lin L; Baeten JM; Palanee-Phillips T; Brown ER; Matovu Kiweewa F; Mgodi NM; Nair G; Siva S; Seils DM; Weinfurt KP;
    AJOB Empir Bioeth; 2019; 10(2):79-87. PubMed ID: 31002583
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Update on microbicide research and development - seeking new HIV prevention tools for women.
    Mertenskoetter T; Kaptur PE
    Eur J Med Res; 2011 Jan; 16(1):1-6. PubMed ID: 21345763
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacokinetics of 2 dapivirine vaginal microbicide gels and their safety vs. Hydroxyethyl cellulose-based universal placebo gel.
    Nel AM; Smythe SC; Habibi S; Kaptur PE; Romano JW
    J Acquir Immune Defic Syndr; 2010 Oct; 55(2):161-9. PubMed ID: 20574411
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Screening for genital and anorectal sexually transmitted infections in HIV prevention trials in Africa.
    Grijsen ML; Graham SM; Mwangome M; Githua P; Mutimba S; Wamuyu L; Okuku H; Price MA; McClelland RS; Smith AD; Sanders EJ
    Sex Transm Infect; 2008 Oct; 84(5):364-70. PubMed ID: 18375645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.